1. Amado RG, Wolf M, Freeman D et al. (2007) Wild-type KRAS is required for Panitumumab efficacy in patients with metastatic colorectal cancer: results from a randomized, controlled trial. Eur J Cancer, Suppl.7LB
2. American Joint Committee on Cancer (AJCC) (2009) AJCC Cancer Staging Manual. 7th edition. Edge SB, Byrd DR, Carducci MA, Compton CC, eds. Springer, Berlin Heidelberg New York
3. Armed Forces Institute of Pathology (AFIP) Atlas of Tumor Pathology. Third Series. Rosai J, Sobin LH (eds) Fascicles 1–32. American Registry of Pathology (AFIP), Washington
4. Armed Forces Institute of Pathology (AFIP) Atlas of Tumor Pathology. Series 4. Silverberg SG, Sobin LH (eds) Fascicles 1–7. American Registry of Pathology (AFIP), Washington DC 20306-6000, from 2004
5. Bundesverband Deutscher Pathologen und Deutsche Gesellschaft für Pathologie (ab 2002ff) Anwendungsleitlinie für verschiedene Tumoren. www.bdp.de